drugset / Trial / NCT00158457
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)
Phase 3
Completed
40 enrolled
French National Agency for Research on AIDS and Viral Hepatitis
Gilead Sciences · collabInstitut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
In the context of Sub-saharian Africa, this trial evaluate one of the most simple treatment available for HIV-1 infected patients. The combination proposed is a triple antiretroviral therapy with only one intake of 3 pills per day. This combination has already been studied in the North countries. Here in Senegal, the efficacy and the compliance to treatment will be evaluated after 24, 48 and 96 weeks of treatment.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | — | — |
| Subject | Tenofovir | Small molecule | — | — |
| Subject | emtricitabine | Other / unclassified | — | — |